These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10588533)

  • 1. The development of a scale of the Guttman type for the assessment of mobility disability in multiple sclerosis.
    De Souza LH
    Clin Rehabil; 1999 Dec; 13(6):476-81. PubMed ID: 10588533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD; Marrie RA; Cohen JA
    Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.
    Block VJ; Lizée A; Crabtree-Hartman E; Bevan CJ; Graves JS; Bove R; Green AJ; Nourbakhsh B; Tremblay M; Gourraud PA; Ng MY; Pletcher MJ; Olgin JE; Marcus GM; Allen DD; Cree BA; Gelfand JM
    J Neurol; 2017 Feb; 264(2):316-326. PubMed ID: 27896433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walk ratio (step length/cadence) as a summary index of neuromotor control of gait: application to multiple sclerosis.
    Rota V; Perucca L; Simone A; Tesio L
    Int J Rehabil Res; 2011 Sep; 34(3):265-9. PubMed ID: 21629125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
    Feys P; Bibby BM; Baert I; Dalgas U
    Eur J Phys Rehabil Med; 2015 Apr; 51(2):207-10. PubMed ID: 25180640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Brunel Balance Assessment: a new measure of balance disability post stroke.
    Tyson SF; DeSouza LH
    Clin Rehabil; 2004 Nov; 18(7):801-10. PubMed ID: 15573837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
    Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating functional decline in patients with Multiple Sclerosis.
    Rosenblum S; Tamar Weiss PL
    Res Dev Disabil; 2010; 31(2):577-86. PubMed ID: 20047816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
    Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
    Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
    Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
    Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walking capacities in multiple sclerosis measured by global positioning system odometer.
    Créange A; Serre I; Levasseur M; Audry D; Nineb A; Boërio D; Moreau T; Maison P;
    Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data.
    Sosnoff JJ; Goldman MD; Motl RW
    Mult Scler; 2010 Jul; 16(7):868-77. PubMed ID: 20534642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.
    Achiron A; Barak Y; Rotstein Z
    Mult Scler; 2003 Oct; 9(5):486-91. PubMed ID: 14582775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis.
    Vukusic S; Confavreux C
    J Neurol Sci; 2003 Feb; 206(2):135-7. PubMed ID: 12559500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of follow-up and disease course].
    Roullet E
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1121-3. PubMed ID: 11787343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.